Abdominal pain in quiescent inflammatory bowel disease

被引:26
作者
Coates, Matthew D. [1 ]
Johri, Ansh [2 ]
Gorrepati, Venkata Subhash [1 ]
Maheshwari, Parth [2 ]
Dalessio, Shannon [1 ]
Walter, Vonn [3 ,4 ]
Stuart, August [1 ]
Koltun, Walter [5 ]
Bernasko, Nana [1 ]
Tinsley, Andrew [1 ]
Williams, Emmanuelle D. [1 ]
Clarke, Kofi [1 ]
机构
[1] Penn State Univ, Dept Med, Div Gastroenterol & Hepatol, Coll Med, Hershey, PA 17033 USA
[2] Penn State Univ, Dept Med, Coll Med, Hershey, PA USA
[3] Penn State Univ, Dept Publ Hlth Sci, Coll Med, Hershey, PA USA
[4] Penn State Univ, Dept Biochem, Coll Med, Hershey, PA USA
[5] Penn State Univ, Dept Surg, Div Colorectal Surg, Coll Med, Hershey, PA USA
关键词
Abdominal pain; Quiescent; Inflammatory bowel disease; Ulcerative colitis; Crohn's disease; QUALITY-OF-LIFE; FUNCTIONAL GASTROINTESTINAL DISORDERS; CROHNS-DISEASE; VISCERAL HYPERSENSITIVITY; ULCERATIVE-COLITIS; MOOD DISORDERS; SYMPTOMS; HEALTH; IMPACT; DIAGNOSIS;
D O I
10.1007/s00384-020-03727-3
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objectives Inflammation is an important driver of abdominal pain in inflammatory bowel disease (IBD). However, some patients in remission still experience pain. We aimed to identify risk factors associated with abdominal pain in quiescent IBD (QP-IBD) and to characterize differences from patients with active disease experiencing pain (AP-IBD). Methods We performed a retrospective analysis utilizing data from our institution's IBD Natural History Registry (January 1, 2015-August 31, 2018). Endoscopic evaluation, concurrent laboratory studies, and validated surveys were completed by participants. Demographic and clinical data were also abstracted. Results We recruited 122 patients with quiescent disease (65f:57 m; 93CD:26UC:3Indeterminate) for participation in this study, 74 (60.7%) had QP-IBD. QP-IBD patients were more likely to have anxiety/depression (71.6% vs. 25.0%,p< 0.001) or to use antidepressants (47.3% vs. 22.9%,p< 0.010), opiates (18.9% vs. 2.1%,p< 0.010), other pain medications (50.0% vs. 18.8%,p< 0.010), or corticosteroids (18.9% vs. 2.1%,p< 0.010). On logistic regression analysis, corticosteroid use, anxious/depressed state, and female gender were each independently associated with QP-IBD (p< 0.050 or less). Compared with AP-IBD patients (n= 110, 59f:51 m; 69CD:38UC:3Indeterminate), QP-IBD patients were more likely to use antidepressants (45.6% vs. 26.4%,p< 0.010). Platelet, white blood cell, C-reactive protein, and sedimentation rate levels were all less likely to be elevated in QP-IBD (allp< 0.050), though 44% exhibited pathological elevation in at least one. Discussion QP-IBD was independently associated with corticosteroid use, anxiety/depression, and female gender. Compared with AP-IBD, QP-IBD patients were more likely to use antidepressants and less likely to exhibit elevated inflammatory markers. However, many QP-IBD patients still demonstrated pathological elevation of these tests, demonstrating the need to develop new noninvasive screening methods for this condition.
引用
收藏
页码:93 / 102
页数:10
相关论文
共 37 条
[1]   Expression of the TRPV1 receptor differs in quiescent inflammatory bowel disease with or without abdominal pain [J].
Akbar, Ayesha ;
Yiangou, Yiangos ;
Facer, Paul ;
Brydon, W. G. ;
Walters, Julian R. F. ;
Anand, Praveen ;
Ghosh, Subrata .
GUT, 2010, 59 (06) :767-774
[2]   Pain and Inflammatory Bowel Disease [J].
Bielefeldt, Klaus ;
Davis, Brian ;
Binion, David G. .
INFLAMMATORY BOWEL DISEASES, 2009, 15 (05) :778-788
[3]  
Boeckxstaens Guy E, 2018, Gastroenterol Hepatol (N Y), V14, P250
[4]   Perceptual responses in patients with inflammatory and functional bowel disease [J].
Chang, L ;
Munakata, J ;
Mayer, EA ;
Schmulson, MJ ;
Johnson, TD ;
Bernstein, CN ;
Saba, L ;
Naliboff, B ;
Anton, PA ;
Matin, K .
GUT, 2000, 47 (04) :497-505
[5]   Gastrointestinal hypoalgesia in inflammatory bowel disease [J].
Coates, Matthew D. ;
Soriano, Christopher ;
Dalessio, Shannon ;
Stuart, August ;
Walter, Vonn ;
Koltun, Walter ;
Bernasko, Nana ;
Tinsley, Andrew ;
Clarke, Kofi ;
Williams, Emmanuelle D. .
ANNALS OF GASTROENTEROLOGY, 2020, 33 (01) :45-52
[6]   Abdominal Pain in Ulcerative Colitis [J].
Coates, Matthew D. ;
Lahoti, Mayank ;
Binion, David G. ;
Szigethy, Eva M. ;
Regueiro, Miguel D. ;
Bielefeldt, Klaus .
INFLAMMATORY BOWEL DISEASES, 2013, 19 (10) :2207-2214
[7]  
Coffey Calvin J, 2018, J Crohns Colitis, V12, P1139, DOI 10.1093/ecco-jcc/jjx187
[8]   Abdominal Pain and the Neurotrophic System in Ulcerative Colitis [J].
Deberry, Jennifer J. ;
Bielefeldt, Klaus ;
Davis, Brian M. ;
Szigethy, Eva M. ;
Hartman, Douglas J. ;
Coates, Matthew D. .
INFLAMMATORY BOWEL DISEASES, 2014, 20 (12) :2330-2339
[9]  
DERWA Y, 2018, THER ADV GASTROENTER, V11
[10]   Functional gastrointestinal disorders and mood disorders in patients with inactive inflammatory bowel disease: Prevalence and impact on health [J].
Farrokhyar, F ;
Marshall, JK ;
Easterbrook, B ;
Irvine, EJ .
INFLAMMATORY BOWEL DISEASES, 2006, 12 (01) :38-46